MXD3 and neoplasm: However, when we compared expression profiles between tumor stages, we found that MXD3 expression increased at higher tumor stages in adrenocortical carcinoma (ACC), KICH, kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma, LICH, and SKCM (Fig. 3B).